Literature DB >> 15499977

[The role of high-resolution CT in the preoperative assessment of chronic otitis media].

Xiuqiang Zhang1, Ying Chen, Qingming Liu, Zaiwen Han, Xiangzhao Li.   

Abstract

OBJECTIVE: To assess the high-resolution CT scan in depicting the middle ear structures.
METHOD: The surgical findings of 51 ears operated on were retrospectively compared with the CT findings. The followings were analysed: diagnostic features of chronic otitis media (COM) on CT status of the middle ear structures (ossicles, facial nerve canal, semicircular canals and tegmen tympani), and anatomical variations. RESULT: The radio-surgical agreement was excellent for the malleus (kappa statistics, k = 0.840) and tegmen (0.788), good for the incus (0.700) and semicircular canals (0.56), but poor for the stapes (0.366) and facial nerve dehiscence (0.310). Potential surgical hazards detected by the scans included: Low lying dura, high jugular bulb, anterior lying sigmoid sinus, facial nerve dehiscence and other situations brought about by the destructive nature of the lesion.
CONCLUSION: There is a good radio-surgical correlation in COM for most middle ear structures except for the integrity of the facial canal and stapes. The scan alerts the surgeon the potential surgical dangers and complications of disease. High-resolution CT scan should be a routine examination prior to middle ear and mastoid surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15499977

Source DB:  PubMed          Journal:  Lin Chuang Er Bi Yan Hou Ke Za Zhi


  2 in total

1.  How Efficacious is HRCT Temporal Bone in Determining the Ossicular Erosion in Cases of Safe and Limited Squamous Type CSOM?

Authors:  Jaskaran Singh; Bhanu Bhardwaj
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-02-17

2.  Correlation of Preoperative 'HRCT Temporal Bone' Findings with 'Surgical Findings' in Unsafe CSOM.

Authors:  Shalini Jadia; Sadat Qureshi; Sandeep Sharma; Kartikeya Mishra
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.